World
AstraZeneca delivers 68 million jabs in 1st quarter
AstraZeneca says it delivered about 68 million doses of its COVID-19 vaccine during the first three months of 2021 after the shot become one of the first approved for widespread use.
The Anglo-Swedish drugmaker on Friday reported $275 million in revenue from sales of the vaccine, or the equivalent of $4.04 per dose. AstraZeneca has pledged that it will deliver the vaccine on a non-profit basis as long as the pandemic lasts.
The company said 30 million doses of the vaccine went to the European Union, 26 million to the U.K., 7 million to Gavi, an alliance that secures vaccines for low-income countries, and 5 million to other nations.